• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Industry inquiries received in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by industry to the FDA, and responses to FDA requests for information from industry.

Information is current as of May 30, 2014

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A5
Nov 2012N/A6
Dec 2012N/A5
Jan 2013N/A9
Feb 2013N/A3
Mar 2013N/A5
Apr 2013N/A8
May 2013N/A11
Jun 2013N/A20
Jul 2013N/A19
Aug 2013N/A23
Sep 2013N/A10

FY 2013 Total: 124

Total number of Industry inquiries responded to in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by industry to the FDA, and responses to FDA requests for information from industry.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetNumber
Oct 2012N/A5
Nov 2012N/A9
Dec 2012N/A2
Jan 2013N/A12
Feb 2013N/A3
Mar 2013N/A3
Apr 2013N/A7
May 2013N/A12
Jun 2013N/A17
Jul 2013N/A19
Aug 2013N/A23
Sep 2013N/A11

FY 2013 Total: 123

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.